Hypoglycemia  >>  Adlyxin (lixisenatide)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Adlyxin (lixisenatide) / Sanofi
NCT02020629: Study on Lixisenatide and Counterregulation to Hypoglycemia

Completed
4
18
Europe
Lixisenatide, Lyxumia
Lund University
Type 2 Diabetes
08/14
08/15
LixiRam, NCT02941367: Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan

Completed
4
184
RoW
Lixisenatide (AVE0010), Lyxumia, Sulfonylurea, metformin, basal insulin
Sanofi
Diabetes Mellitus, Type 2
08/17
08/17

Download Options